Abbott Laboratories (ABT) Q4 2015 Earnings Results

Abbott Laboratories Beats on EPS, Stock Down 9.3%

Abbott Laboratories reported an EPS of $0.62, slightly beating expectations. However, the stock fell by 9.3%, indicating investor concerns despite the earnings beat. The lack of revenue data and management commentary may have contributed to the negative stock reaction.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.62	N/A	+1.31%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Unknown

No transcript is on record, and the analysis is based solely on numerical results.

Abbott Laboratories Beats on EPS, Stock Down 9.3%

Key numbers

Management commentary

Abbott Laboratories

More earnings this week

Abbott Laboratories Beats on EPS, Stock Down 9.3%

Key numbers

Management commentary